Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India
Background. A cross-sectional study among individuals receiving second-line antiretroviral
treatment was conducted to report on the level of detectable viremia and the types of drug …
treatment was conducted to report on the level of detectable viremia and the types of drug …
Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India
Background HIV type-1 (HIV-1) monitoring in resource-limited settings relies on clinical and
immunological assessment. The objective of this study was to study the frequency and …
immunological assessment. The objective of this study was to study the frequency and …
Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients
L Rajesh, R Karunaianantham… - AIDS Research and …, 2009 - liebertpub.com
There is limited information on the prevalence and pattern of HIV drug-resistant mutations
(DRMs) among HIV-1-coinfected tuberculosis (TB) patients before and after antiretroviral …
(DRMs) among HIV-1-coinfected tuberculosis (TB) patients before and after antiretroviral …
One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India
HIV-infected patients receiving antiretroviral (ARV) therapy (ART) in India are not all
adequately virally suppressed. We analyzed ARV drug resistance in adults receiving ART in …
adequately virally suppressed. We analyzed ARV drug resistance in adults receiving ART in …
Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and …
Genotyping reveal emergence of drug resistance (DR)-related mutations in HIV-1 protease
(PR) gene in the first-line treatment failure patients as per Stanford DR database. In order to …
(PR) gene in the first-line treatment failure patients as per Stanford DR database. In order to …
Replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on HIV subtype C
KL Armstrong, TH Lee, M Essex - Antimicrobial agents and …, 2011 - Am Soc Microbiol
Single-dose nevirapine (NVP) is quite effective in preventing transmission of the human
immunodeficiency virus (HIV) from mother to child; however, many women develop …
immunodeficiency virus (HIV) from mother to child; however, many women develop …
HIV subtype, epidemiological and mutational correlations in patients from Paraná, Brazil
MMG da Silva, FQ Telles, CA da Cunha… - The Brazilian Journal of …, 2010 - Elsevier
OBJECTIVE: Analyze patients with HIV infection from Curitiba, Paraná, their epidemiological
characteristics and HIV RAM. METHODS: Patients regularly followed in an ID Clinic had …
characteristics and HIV RAM. METHODS: Patients regularly followed in an ID Clinic had …
Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India
AJ Kandathil, R Kannangai, VP Verghese… - Indian journal of medical …, 2009 - Elsevier
Purpose: There has been an increase in the number of individuals administered
antiretroviral therapy (ART) in India but treatment outcome is hampered by increasing …
antiretroviral therapy (ART) in India but treatment outcome is hampered by increasing …
Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance
Prevalence of etravirine genotypic resistance was assessed among 92 HIV-1C-infected
patients failing nevirapine and efavirenz-based regimens from a cohort of 552 Indian …
patients failing nevirapine and efavirenz-based regimens from a cohort of 552 Indian …
Prevalence of HIV drug resistance mutation in the northern Indian population after failure of the first line antiretroviral therapy
There is limited information available about the prevalence and pattern of human
immunodeficiency virus (HIV) drug resistance mutations (DRMs) among antiretroviral …
immunodeficiency virus (HIV) drug resistance mutations (DRMs) among antiretroviral …